Glenview Capital Management, Tenet Healthcare's largest shareholder, is pulling its two representatives off the hospital company's board. » Read More
By: Bob Woods, special to CNBC.com
This emerging biotech movement promises to radically overhaul the arduous process of bringing new drugs, foods and cosmetics to market. » Read More
By: Chris Morris, special to CNBC.com
Emmaus Medical CEO Dr. Yutaka Niihara spent much of his career developing Endari, a recently approved FDA drug to treat sickle cell anemia. » Read More
Faux mini-towns from the 1950s and '60s are emerging for dementia and Alzheimer's sufferers in the US. It is reminiscence therapy.
Hospitals are offering their own insurance plans and could easily destroy the private insurance industry as we know it.
The rate of out-of-network doctor's bills for customers of one large insurer jumped when a company called Emcare entered a hospital, N.Y. Times reports.
A vaccine intended to control meningitis could hold the answers to protecting the population from the gonorrhea superbug.
Sen. John McCain's diagnosis of glioblastoma Wednesday night once again sheds light on this devastating illness and the need to find a cure.
While the U.S. will spend more on health care in the long-term, expect lots of uncertainty in the short-term, says Charles Bobrinskoy of Ariel Investments.
Some Medicare beneficiaries are being prescribed opioids by 10 or more doctors, Propublica reports.
Alexi Nazem, CEO and co-founder of Nomad, speaks with CNBC’s ‘Squawk Alley’ about his health-care startup and how it addresses the shortage of nurses and medical professionals across the US.
The U.S. has a greater divide between health care between the rich and the poor than 10 other countries, according to a new Commonwealth Fund study.
A medical practice can earn $200,000 in "gross profit" a year by seeing two CoolSculpting patients a week, N.Y. Times reports.
A current draft compels the F.D.A. to speed medical devices onto the market — and into patients — faster than ever, N.Y. Times reports.
Singapore-based Quadria Capital is growing in Vietnam and expanding its holdings in Singapore.
On the Senate's health-care bill, insurers and hospitals have starkly different views, Vox reports.
Former VP Joe Biden believes pooling data on cancer patients is key to finding a cure—a main focus of his Cancer Moonshot initiative.
Hospitals have benefited from treating more patients with health insurance. The Senate's proposal could shrink already slim margins.
Larry Robbins, CEO of Glenview Capital, speaks with CNBC’s David Faber on how Congress’ attempts at health-care reform could affect the small and big players in the health-care sector.
Get the best of CNBC in your inbox